The future of antimalarials:: artemisinins and synthetic endoperoxides

被引：16

作者：

Bégué, JP ^{[1
]}

Bonnet-Delpon, D ^{[1
]}

机构：

[1] CNRS, UMR 8076, BIOCIS, Ctr Etudes Pharmaceut, F-92296 Chatenay Malabry, France

来源：

DRUGS OF THE FUTURE | 2005年 / 30卷 / 05期

关键词：

D O I：

10.1358/dof.2005.030.05.901987

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Malaria is one of the most widespread infectious diseases in the world. Plasmodium falciparum, the main strain responsible for human malaria, has developed resistance to most available antimalarial agents. Artemisinin is a sesquiterpenic lactone isolated from Artemisia annua L., a plant used in traditional Chinese medicine. It is very effective in treating drug-resistant malaria and appears very promising for fighting the disease. Numerous investigations are currently being performed with the aim of elucidating the mechanism of action, determining efficient clinical uses and discovering new drugs with better pharmacological properties. Most investigations revolve around the highly unusual endoperoxide present in artemisinin, which is responsible for the antimalarial activity. Several strategies have been developed for the design of semisynthetic and synthetic endoperoxides with greater metabolic and hydrolytic stability than artemisinin itself. Here we present an overview of this area.

引用

页码：509 / 518

页数：10

共 78 条

[1] Synthesis and in vivo antimalarial activity of 12 alpha-trifluoromethyl-hydroartemisinin [J].

Abouabdellah, A ;

Begue, JP ;

BonnetDelpon, D ;

Gantier, JC ;

Nga, TTT ;

Thac, TD .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (22) :2717-2720

[2]

ARAUJO NC, IN PRESS J MED CHEM

[3] Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies [J].

Avery, MA ;

Alvim-Gaston, M ;

Rodrigues, CR ;

Barreiro, EJ ;

Cohen, FE ;

Sabnis, YA ;

Woolfrey, JR .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :292-303

[4] Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study [J].

Barnes, KI ;

Mwenechanya, J ;

Tembo, M ;

Mcilleron, H ;

Folb, PI ;

Ribeiro, I ;

Little, F ;

Gomes, M ;

Molyneux, ME .

LANCET, 2004, 363 (9421) :1598-1605

[5]

BEGUE JP, Patent No. 03035651

[6] The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin [J].

Bhisutthibhan, J ;

Pan, XQ ;

Hossler, PA ;

Walker, DJ ;

Yowell, CA ;

Carlton, J ;

Dame, JB ;

Meshnick, SR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) :16192-16198

[7] The effect of 10α-trifluoromethylhydroartemisinin on Plasmodium berghei infection and its toxicity in experimental animals [J].

Binh, PD ;

Cong, LD ;

Van Nhu, T ;

Tien, NT ;

Nhan, DH ;

Bégue, JP ;

Bonnet-Delpon, D ;

Nga, TTT .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2002, 96 (06) :677-683

[8]

Breman JG, 2001, AM J TROP MED HYG, V64, P1

[9]

China Cooperative Research Group on quighaosu and its derivatives, 1982, J TRADIT CHIN MED, V2, P9

[10] First synthesis of 10α-(trifluoromethyl)deoxoartemisinin [J].

Chorki, F ;

Grellepois, F ;

Crousse, B ;

Hoang, VD ;

Van Hung, N ;

Bonnet-Delpon, D ;

Bégué, JP .

ORGANIC LETTERS, 2002, 4 (05) :757-759

← 1 2 3 4 5 6 7 8 →